CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive loss
Balance (in shares) at Mar. 31, 2022		47,338,660
Balance at Mar. 31, 2022	$ 411,229	$ 47	$ 723,359	$ (311,204)	$ (973)
Increase (decrease) in Stockholders' Equity
Shares issued during period (in shares)		1,686,438
Issuance of common stock through ATM sales, net of offering costs	31,037	$ 2	31,035
Foreign currency translation adjustment	1,737				1,737
Unrealized loss on short-term investments	(244)				(244)
Exercise of stock options (in shares)		124,028
Exercise of pre-funded warrants	1,562		1,562
Vesting of RSUs (in shares)		149,341
Stock-based compensation expense	7,194		7,194
Net loss	(42,253)			(42,253)
Balance (in shares) at Jun. 30, 2022		49,298,467
Balance at Jun. 30, 2022	410,262	$ 49	763,150	(353,457)	520
Balance (in shares) at Mar. 31, 2022		47,338,660
Balance at Mar. 31, 2022	$ 411,229	$ 47	723,359	(311,204)	(973)
Increase (decrease) in Stockholders' Equity
Shares issued during period (in shares)	340,000
Balance (in shares) at Mar. 31, 2023		56,676,313
Balance at Mar. 31, 2023	$ 555,292	$ 57	1,034,994	(485,488)	5,729
Increase (decrease) in Stockholders' Equity
Foreign currency translation adjustment	(1,305)				(1,305)
Unrealized loss on short-term investments	$ (458)				(458)
Exercise of pre-funded warrants		1,922,655
Exercise of stock options (in shares)	96,146	96,146
Exercise of pre-funded warrants	$ 1,209		1,209
Vesting of RSUs (in shares)		281,211
Stock-based compensation expense	8,846		8,846
Net loss	(49,555)			(49,555)
Balance (in shares) at Jun. 30, 2023		58,976,325
Balance at Jun. 30, 2023	$ 514,029	$ 57	$ 1,045,049	$ (535,043)	$ 3,966